Rania Latif-Abdel

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Response to Letter to the Editor: Commending the Feasibility of CYP2C19 Pharmacogenetic Testing in Personalized Antiplatelet Therapy-Insights and Perspectives.

Response to Letter to the Editor: Commending the Feasibility of CYP2C19 Pharmacogenetic Testing in Personalized Antiplatelet Therapy-Insights and Perspectives.

Journal: Clinical therapeutics

Published: February 09, 2026

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.

Journal: Clinical therapeutics

Published: May 19, 2025

Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis.

Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis.

Journal: Clinical drug investigation

Published: November 21, 2024

Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar.

Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar.

Journal: Journal of pharmaceutical policy and practice

Published: October 29, 2024

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery: a multi-ancestry study in 10 960 individuals from 9 biobanks.

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery: a multi-ancestry study in 10 960 individuals from 9 biobanks.

Journal: medRxiv : the preprint server for health sciences

Published: September 24, 2024

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.

Journal: Nature medicine

Published: September 03, 2024

QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.

QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.

Journal: Clinical and translational science

Published: February 26, 2024

A population study of clinically actionable genetic variation affecting drug response from the Middle East.

A population study of clinically actionable genetic variation affecting drug response from the Middle East.

Journal: NPJ genomic medicine

Published: July 19, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026